Literature DB >> 32887528

Neurotechnologies as tools for cognitive rehabilitation in stroke patients.

Laurijn R Draaisma1,2, Maximilian J Wessel1,2, Friedhelm C Hummel1,2,3.   

Abstract

INTRODUCTION: Cognitive impairments are one of the most common remaining symptoms after a stroke. The use of neurotechnologies to enhance cognitive performance is a rapidly emerging field with encouraging results. AREAS COVERED: Here, the authors empirically review the respective literature and critically discuss the technologies that are currently most often used for cognitive enhancement in stroke patients, which are computerized cognitive training, virtual reality, noninvasive brain stimulation and brain-computer interfaces. The authors describe their advantages/disadvantages and the challenges and limitations to overcome. EXPERT OPINION: Although the current results are promising, more research is needed to be able to make conclusive statements and translate these approaches successfully in daily clinical life. Multidiscipline collaborations could aid to improve current neurotechnologies and provide guidelines for future implementations.

Entities:  

Keywords:  BCI; CCT; Stroke; VR; brain stimulation; cognition; neurotechnology; rTMS; rehabilitation; tDCS

Mesh:

Year:  2020        PMID: 32887528     DOI: 10.1080/14737175.2020.1820324

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  2 in total

Review 1.  Occupational therapy for cognitive impairment in stroke patients.

Authors:  Elizabeth Gibson; Chia-Lin Koh; Sally Eames; Sally Bennett; Anna Mae Scott; Tammy C Hoffmann
Journal:  Cochrane Database Syst Rev       Date:  2022-03-29

2.  The Frequency Effect of the Motor Imagery Brain Computer Interface Training on Cortical Response in Healthy Subjects: A Randomized Clinical Trial of Functional Near-Infrared Spectroscopy Study.

Authors:  Qiang Lin; Yanni Zhang; Yajie Zhang; Wanqi Zhuang; Biyi Zhao; Xiaomin Ke; Tingting Peng; Tingting You; Yongchun Jiang; Anniwaer Yilifate; Wei Huang; Lingying Hou; Yaoyao You; Yaping Huai; Yaxian Qiu; Yuxin Zheng; Haining Ou
Journal:  Front Neurosci       Date:  2022-03-31       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.